People
Laboratory members
Photo |
Who |
Research interests |
---|---|---|
Anna Wu
|
Akinyemi O. Oni-Orisan, PharmD, PhD Principal Investigator X Profile (formerly Twitter): @Akinyemi_OO Introduction: Brains and Braggadocio (audio, 50 minutes). Pronouns: he/him/his |
Clinical validation of pharmacogenetic associations for cardiovascular therapies. |
|
Anita Chaphekar, DO Clinical Fellow Fellow Perspective: Anita Chaphekar on Finding Your Medical Passion Pronouns: she/her/hers |
Optimizing real-world health data and electronic medical records to evaluate pharmacologic dosing regimens in pediatric and adolescent populations. |
|
Michael Douglas, MS Program Manager X Profile (formerly Twitter): @MDouglas_MS Pronouns: he/him/his |
Evaluating the equitable implementation of new technologies in precision medicine for cardiovascular disease, cancer, and pharmacogenomics. |
|
Tanushree Haldar, PhD Data Scientist Pronouns: she/her/hers |
Implementing statistical methods in both local and cloud computing platforms to analyze biomedical data with special emphasis on pharmacogenomics and genetic epidemiology. |
|
Joseph Harmon, BS Research Associate Pronouns: he/him/his |
Analyzing the pharmacokinetics and pharmacodynamics of relevant medications using patient biospecimens, self-reported surveys, and electronic health records. |
|
Mark Kvale, PhD Programmer/Analyst (part-time) Pronouns: he/him/his |
Using statistical genetics and machine learning techniques to analyze data, to infer results in large-scale genetic and genomic experiments, and to develop novel approaches to analysis. |
|
James Najera, MS PhD Student in Epidemiology and Translational Science Pronouns: he/him/his |
Using population genetics, gene-environment interaction, and integration of omics for big data analytics. As a doctoral student, I aim to address health disparities among underrepresented communities in the field of genomic research. |
Alumni
Photo | Name, Role, Years | Project | Now | |
---|---|---|---|---|
Janille Miranda, PharmD Intensive Research Project PharmD student 2021–2023 |
Candidate genetic variants of statin-induced myotoxicity. | PGY-1 pharmacy resident, Stanford University. | ||
Mari Cayabyab, PharmD Clinical Pharmacology and Therapeutics (CPT) postdoctoral fellow 2020–2022 |
Coronary heart disease polygenic risk score and secondary prevention of myocardial infarction. Abstract/Award: Cayabyab et al. Clin Pharmacol Ther. 2022;111: S63. Jason Morrow Trainee Award winner (2nd-best trainee abstract at the conference). |
Clinical pharmacy specialist – pharmacogenomics, University of Pennsylvania. | ||
Siem Tsegay Summer Student Research Program (SSRP) undergraduate student 2022 |
Pilot study to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of tamsulosin deprescribing | Undergraduate student, Macalester College. | ||
Brian Lu, PharmD Pharmacogenomics Discovery Project PharmD student 2019–2021 |
Effect of SLCO1B1 T521C on statin-related myotoxicity with use of lovastatin and atorvastatin. Publication: Lu et al. Clin Pharmacol Ther. 2021 Sep;110(3):733-740. PMID: 34114646. |
PGY-2 infectious diseases pharmacy resident, Stanford University. |